Gene · 5281
Papers2,279
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,279
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Placental Growth Factor and Pregnancy-Associated Plasma Protein-A as Potential Early Predictors of Gestational Diabetes Mellitus. | Medicina (Kaunas) | 2023 | 36837599 | PubTator, text mining | PubMed |
| Systemic Cytokines in Retinopathy of Prematurity. | J Pers Med | 2023 | 36836525 | PubTator, text mining | PubMed |
| Secretome of Adipose-Derived Stem Cells Cultured in Platelet Lysate Improves Migration and Viability of Keratinocytes. | Int J Mol Sci | 2023 | 36834932 | PubTator, text mining | PubMed |
| Induced Pluripotent Stem Cell-Derived Organoids: Their Implication in COVID-19 Modeling. | Int J Mol Sci | 2023 | 36834870 | PubTator, text mining | PubMed |
| Preeclampsia: Recent Advances in Predicting, Preventing, and Managing the Maternal and Fetal Life-Threatening Condition. | Int J Environ Res Public Health | 2023 | 36833689 | PubTator, text mining | PubMed |
| Metastatic colorectal cancer: mechanisms and emerging therapeutics. | Trends Pharmacol Sci | 2023 | 36828759 | PubTator, text mining | PubMed |
| Real-World Outcomes of Anti-VEGF Therapy in Diabetic Macular Oedema: Barriers to Treatment Success and Implications for Low/Lower-Middle-Income Countries. | Ophthalmol Ther | 2023 | 36821027 | PubTator, text mining | PubMed |
| Lymphangioleiomyomatosis: Searching for potential biomarkers. | Front Med (Lausanne) | 2023 | 36817769 | PubTator, text mining | PubMed |
| Role of Anti-Vascular Endothelial Growth Factor (Anti-VEGF) in the Treatment of Retinopathy of Prematurity: A Narrative Review in the Context of Middle-Income Countries. | Pediatric Health Med Ther | 2023 | 36814935 | PubTator, text mining | PubMed |
| Associations between the human immune system and gut microbiome with neurodevelopment in the first 5 years of life: A systematic scoping review. | Dev Psychobiol | 2023 | 36811373 | PubTator, text mining | PubMed |
| Antitumor therapy for breast cancer: Focus on tumor-associated macrophages and nanosized drug delivery systems. | Cancer Med | 2023 | 36794651 | PubTator, text mining | PubMed |
| Visceral adipose tissue secretome from early and late-stage oesophageal cancer patients differentially affects effector and regulatory T cells. | J Cancer Res Clin Oncol | 2023 | 36790524 | PubTator, text mining | PubMed |
| The sFlt-1/PlGF Ratio in Pregnant Patients Affected by COVID-19. | J Clin Med | 2023 | 36769707 | PubTator, text mining | PubMed |
| The Correlation between Waist Circumference and the Pro-Inflammatory Adipokines in Diabetic Retinopathy of Type 2 Diabetes Patients. | Int J Mol Sci | 2023 | 36768360 | PubTator, text mining | PubMed |
| Utility of sFtl-1 and Placental Growth Factor Ratio for Adequate Preeclampsia Management. | Healthcare (Basel) | 2023 | 36766955 | PubTator, text mining | PubMed |
| Cytokine- and Vascular Endothelial Growth Factor-Related Gene-Based Genome-Wide Association Study of Low-Dose Ketamine Infusion in Patients with Treatment-Resistant Depression. | CNS Drugs | 2023 | 36763263 | PubTator, text mining | PubMed |
| Premature infants born <28 weeks with acute kidney injury have increased bronchopulmonary dysplasia rates. | Pediatr Res | 2023 | 36759749 | PubTator, text mining | PubMed |
| Proteomic analysis predicts anti-angiogenic resistance in recurred glioblastoma. | J Transl Med | 2023 | 36732815 | PubTator, text mining | PubMed |
| Vascular endothelial growth factor A is a potential prognostic biomarker and correlates with immune cell infiltration in hepatocellular carcinoma. | J Cell Mol Med | 2023 | 36729917 | PubTator, text mining | PubMed |
| Turning adversity into opportunity: Small extracellular vesicles as nanocarriers for tumor-associated macrophages re-education. | Bioeng Transl Med | 2023 | 36684102 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5281/papers?page=15